| Senator reveals results of opioid inquiry into Insys | | | BOSTON (Reuters) - Insys Therapeutics Inc sought to manipulate insurance payment approval for an opioid cancer pain drug called Subsys even if for inappropriate uses, according to a U.S. Senate report on the opioid crisis released on Wednesday. |
| |
| Bristol-Myers says FDA places partial hold on Opdivo myeloma trials | | | (Reuters) - The U.S. Food and Drug Administration has placed a partial hold on three clinical trials testing Bristol-Myers Squibb's immunotherapy Opdivo in combination with other medicines for multiple myeloma due to risks seen in similar studies involving a rival drug, the company said on Wednesday. |
| |
| Anthem cuts back Obamacare coverage in Kentucky | | | NEW YORK (Reuters) - U.S. health insurer Anthem Inc said on Wednesday that it will offer Obamacare plans in only about half of the counties in Kentucky next year, after covering the whole state in 2017. |
| |
| | |
